A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Aron Hussid e PAZIN FILHO, Antonio. Lung ultrasound in a patient with ARDS secondary to pancreatitis. Chest, v. 158, n. 2, p. e85-e87, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.chest.2019.09.045. Acesso em: 20 out. 2025.
APA
Ferreira, A. H., & Pazin Filho, A. (2020). Lung ultrasound in a patient with ARDS secondary to pancreatitis. Chest, 158( 2), e85-e87. doi:10.1016/j.chest.2019.09.045
NLM
Ferreira AH, Pazin Filho A. Lung ultrasound in a patient with ARDS secondary to pancreatitis [Internet]. Chest. 2020 ; 158( 2): e85-e87.[citado 2025 out. 20 ] Available from: https://doi.org/10.1016/j.chest.2019.09.045
Vancouver
Ferreira AH, Pazin Filho A. Lung ultrasound in a patient with ARDS secondary to pancreatitis [Internet]. Chest. 2020 ; 158( 2): e85-e87.[citado 2025 out. 20 ] Available from: https://doi.org/10.1016/j.chest.2019.09.045
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
EVORA, Paulo Roberto Barbosa. Broad spectrum vasopressors support sparing strategies in vasodilatory shock beyond the vascular receptors [Carta]. Chest. Amsterdam: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.chest.2019.08.2211. Acesso em: 20 out. 2025. , 2020
APA
Evora, P. R. B. (2020). Broad spectrum vasopressors support sparing strategies in vasodilatory shock beyond the vascular receptors [Carta]. Chest. Amsterdam: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1016/j.chest.2019.08.2211
NLM
Evora PRB. Broad spectrum vasopressors support sparing strategies in vasodilatory shock beyond the vascular receptors [Carta] [Internet]. Chest. 2020 ; 157( 2): 471-472.[citado 2025 out. 20 ] Available from: https://doi.org/10.1016/j.chest.2019.08.2211
Vancouver
Evora PRB. Broad spectrum vasopressors support sparing strategies in vasodilatory shock beyond the vascular receptors [Carta] [Internet]. Chest. 2020 ; 157( 2): 471-472.[citado 2025 out. 20 ] Available from: https://doi.org/10.1016/j.chest.2019.08.2211
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MCLAUGHLIN, Vallerie V et al. Results of an expert consensus survey on the treatment of pulmonary arterial hypertension with oral prostacyclin pathway agents. Chest, v. 157, n. 4, p. 955-965, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.chest.2019.10.043. Acesso em: 20 out. 2025.
APA
Mclaughlin, V. V., Channick, R., Marco, T. D., Farber, H. W., Gaine, S., Galie, N., et al. (2020). Results of an expert consensus survey on the treatment of pulmonary arterial hypertension with oral prostacyclin pathway agents. Chest, 157( 4), 955-965. doi:10.1016/j.chest.2019.10.043
NLM
Mclaughlin VV, Channick R, Marco TD, Farber HW, Gaine S, Galie N, Krasuski RA, Preston I, Souza R de, Coghlan JG. Results of an expert consensus survey on the treatment of pulmonary arterial hypertension with oral prostacyclin pathway agents [Internet]. Chest. 2020 ; 157( 4): 955-965.[citado 2025 out. 20 ] Available from: https://doi.org/10.1016/j.chest.2019.10.043
Vancouver
Mclaughlin VV, Channick R, Marco TD, Farber HW, Gaine S, Galie N, Krasuski RA, Preston I, Souza R de, Coghlan JG. Results of an expert consensus survey on the treatment of pulmonary arterial hypertension with oral prostacyclin pathway agents [Internet]. Chest. 2020 ; 157( 4): 955-965.[citado 2025 out. 20 ] Available from: https://doi.org/10.1016/j.chest.2019.10.043
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KAWANO-DOURADO, Leticia et al. Baseline Characteristics and Progression of a Spectrum of Interstitial Lung Abnormalities and Disease in Rheumatoid Arthritis. Chest, v. 158, n. 4, p. 1546-1554, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.chest.2020.04.061. Acesso em: 20 out. 2025.
APA
Kawano-dourado, L., Doyle, T. J., Bonfiglioli, K., Sawamura, M. V. Y., Nakagawa, R. H., Arimura, F. E., et al. (2020). Baseline Characteristics and Progression of a Spectrum of Interstitial Lung Abnormalities and Disease in Rheumatoid Arthritis. Chest, 158( 4), 1546-1554. doi:10.1016/j.chest.2020.04.061
NLM
Kawano-dourado L, Doyle TJ, Bonfiglioli K, Sawamura MVY, Nakagawa RH, Arimura FE, Lee HJ, Rangel DA de S, Carvalho CRR de, Kairalla RA. Baseline Characteristics and Progression of a Spectrum of Interstitial Lung Abnormalities and Disease in Rheumatoid Arthritis [Internet]. Chest. 2020 ; 158( 4): 1546-1554.[citado 2025 out. 20 ] Available from: https://doi.org/10.1016/j.chest.2020.04.061
Vancouver
Kawano-dourado L, Doyle TJ, Bonfiglioli K, Sawamura MVY, Nakagawa RH, Arimura FE, Lee HJ, Rangel DA de S, Carvalho CRR de, Kairalla RA. Baseline Characteristics and Progression of a Spectrum of Interstitial Lung Abnormalities and Disease in Rheumatoid Arthritis [Internet]. Chest. 2020 ; 158( 4): 1546-1554.[citado 2025 out. 20 ] Available from: https://doi.org/10.1016/j.chest.2020.04.061
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DRAGER, Luciano Ferreira e LORENZI FILHO, Geraldo. Rebuttal From Drs Drager and Lorenzi-Filho [Editorial]. Chest. Amsterdam: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.chest.2019.04.006. Acesso em: 20 out. 2025. , 2019
APA
Drager, L. F., & Lorenzi Filho, G. (2019). Rebuttal From Drs Drager and Lorenzi-Filho [Editorial]. Chest. Amsterdam: Faculdade de Medicina, Universidade de São Paulo. doi:10.1016/j.chest.2019.04.006
NLM
Drager LF, Lorenzi Filho G. Rebuttal From Drs Drager and Lorenzi-Filho [Editorial] [Internet]. Chest. 2019 ; 155( 6): 1101-1102.[citado 2025 out. 20 ] Available from: https://doi.org/10.1016/j.chest.2019.04.006
Vancouver
Drager LF, Lorenzi Filho G. Rebuttal From Drs Drager and Lorenzi-Filho [Editorial] [Internet]. Chest. 2019 ; 155( 6): 1101-1102.[citado 2025 out. 20 ] Available from: https://doi.org/10.1016/j.chest.2019.04.006
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DRAGER, Luciano Ferreira et al. Sleepiness and Cardiometabolic Impact of Short Sleep Duration and OSA What About the Clock? Response [Carta]. Chest. Amsterdam: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.chest.2019.08.2171. Acesso em: 20 out. 2025. , 2019
APA
Drager, L. F., Santos, R. B., Silva, W. A., Parise, B. K., Giatti, S., Aielo, A. N., et al. (2019). Sleepiness and Cardiometabolic Impact of Short Sleep Duration and OSA What About the Clock? Response [Carta]. Chest. Amsterdam: Faculdade de Medicina, Universidade de São Paulo. doi:10.1016/j.chest.2019.08.2171
NLM
Drager LF, Santos RB, Silva WA, Parise BK, Giatti S, Aielo AN, Souza SP, Lotufo PA, Benseñor IJM. Sleepiness and Cardiometabolic Impact of Short Sleep Duration and OSA What About the Clock? Response [Carta] [Internet]. Chest. 2019 ; 156( 6): 1274-1275.[citado 2025 out. 20 ] Available from: https://doi.org/10.1016/j.chest.2019.08.2171
Vancouver
Drager LF, Santos RB, Silva WA, Parise BK, Giatti S, Aielo AN, Souza SP, Lotufo PA, Benseñor IJM. Sleepiness and Cardiometabolic Impact of Short Sleep Duration and OSA What About the Clock? Response [Carta] [Internet]. Chest. 2019 ; 156( 6): 1274-1275.[citado 2025 out. 20 ] Available from: https://doi.org/10.1016/j.chest.2019.08.2171
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OU, Qiong et al. The effects of long-term CPAP on weight change in patients with comorbid OSA and cardiovascular disease data from the SAVE Trial. Chest, v. 155, n. 4, p. 720-729, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.chest.2018.08.1082. Acesso em: 20 out. 2025.
APA
Ou, Q., Chen, B., Loftier, K. A., Luo, Y., Zhang, X., Chen, R., et al. (2019). The effects of long-term CPAP on weight change in patients with comorbid OSA and cardiovascular disease data from the SAVE Trial. Chest, 155( 4), 720-729. doi:10.1016/j.chest.2018.08.1082
NLM
Ou Q, Chen B, Loftier KA, Luo Y, Zhang X, Chen R, Wang Q, Drager LF, Lorenzi Filho G, Hlavac M. The effects of long-term CPAP on weight change in patients with comorbid OSA and cardiovascular disease data from the SAVE Trial [Internet]. Chest. 2019 ; 155( 4): 720-729.[citado 2025 out. 20 ] Available from: https://doi.org/10.1016/j.chest.2018.08.1082
Vancouver
Ou Q, Chen B, Loftier KA, Luo Y, Zhang X, Chen R, Wang Q, Drager LF, Lorenzi Filho G, Hlavac M. The effects of long-term CPAP on weight change in patients with comorbid OSA and cardiovascular disease data from the SAVE Trial [Internet]. Chest. 2019 ; 155( 4): 720-729.[citado 2025 out. 20 ] Available from: https://doi.org/10.1016/j.chest.2018.08.1082
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DRAGER, Luciano Ferreira et al. OSA, Short Sleep Duration, and Their Interactions With Sleepiness and Cardiometabolic Risk Factors in Adults The ELSA-Brasil Study. Chest, v. 155, n. 6, p. 1190-1198, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.chest.2018.12.003. Acesso em: 20 out. 2025.
APA
Drager, L. F., Santos, R. B., Silva, W. A., Parise, B. K., Giatti, S., Aielo, A. N., et al. (2019). OSA, Short Sleep Duration, and Their Interactions With Sleepiness and Cardiometabolic Risk Factors in Adults The ELSA-Brasil Study. Chest, 155( 6), 1190-1198. doi:10.1016/j.chest.2018.12.003
NLM
Drager LF, Santos RB, Silva WA, Parise BK, Giatti S, Aielo AN, Souza SP, Furlan SF, Lorenzi Filho G, Lotufo PA, Benseñor IJM. OSA, Short Sleep Duration, and Their Interactions With Sleepiness and Cardiometabolic Risk Factors in Adults The ELSA-Brasil Study [Internet]. Chest. 2019 ; 155( 6): 1190-1198.[citado 2025 out. 20 ] Available from: https://doi.org/10.1016/j.chest.2018.12.003
Vancouver
Drager LF, Santos RB, Silva WA, Parise BK, Giatti S, Aielo AN, Souza SP, Furlan SF, Lorenzi Filho G, Lotufo PA, Benseñor IJM. OSA, Short Sleep Duration, and Their Interactions With Sleepiness and Cardiometabolic Risk Factors in Adults The ELSA-Brasil Study [Internet]. Chest. 2019 ; 155( 6): 1190-1198.[citado 2025 out. 20 ] Available from: https://doi.org/10.1016/j.chest.2018.12.003
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MADEIRO, Fernanda et al. Transmission of Oral Pressure Compromises Oronasal CPAP Efficacy in the Treatment of OSA. Chest, v. 156, n. 6, p. 1187-1194, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.chest.2019.05.024. Acesso em: 20 out. 2025.
APA
Madeiro, F., Andrade, R. G. S. de, Piccin, V. S., Pinheiro, G. do L., Moriya, H. T., Genta, P. R., & Lorenzi Filho, G. (2019). Transmission of Oral Pressure Compromises Oronasal CPAP Efficacy in the Treatment of OSA. Chest, 156( 6), 1187-1194. doi:10.1016/j.chest.2019.05.024
NLM
Madeiro F, Andrade RGS de, Piccin VS, Pinheiro G do L, Moriya HT, Genta PR, Lorenzi Filho G. Transmission of Oral Pressure Compromises Oronasal CPAP Efficacy in the Treatment of OSA [Internet]. Chest. 2019 ; 156( 6): 1187-1194.[citado 2025 out. 20 ] Available from: https://doi.org/10.1016/j.chest.2019.05.024
Vancouver
Madeiro F, Andrade RGS de, Piccin VS, Pinheiro G do L, Moriya HT, Genta PR, Lorenzi Filho G. Transmission of Oral Pressure Compromises Oronasal CPAP Efficacy in the Treatment of OSA [Internet]. Chest. 2019 ; 156( 6): 1187-1194.[citado 2025 out. 20 ] Available from: https://doi.org/10.1016/j.chest.2019.05.024
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
YAGIHARA, Fabiana e LORENZI FILHO, Geraldo e SANTOS-SILVA, Rogerio. Patients with OSA are perceived as younger following treatment with CPAP. Chest, v. 156, n. 3, p. 553-561, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.chest.2019.03.015. Acesso em: 20 out. 2025.
APA
Yagihara, F., Lorenzi Filho, G., & Santos-Silva, R. (2019). Patients with OSA are perceived as younger following treatment with CPAP. Chest, 156( 3), 553-561. doi:10.1016/j.chest.2019.03.015
NLM
Yagihara F, Lorenzi Filho G, Santos-Silva R. Patients with OSA are perceived as younger following treatment with CPAP [Internet]. Chest. 2019 ; 156( 3): 553-561.[citado 2025 out. 20 ] Available from: https://doi.org/10.1016/j.chest.2019.03.015
Vancouver
Yagihara F, Lorenzi Filho G, Santos-Silva R. Patients with OSA are perceived as younger following treatment with CPAP [Internet]. Chest. 2019 ; 156( 3): 553-561.[citado 2025 out. 20 ] Available from: https://doi.org/10.1016/j.chest.2019.03.015
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DRAGER, Luciano Ferreira e LORENZI FILHO, Geraldo. POINT: Should sleep studies be performed for all patients with poorly controlled hypertension? yes [Editorial]. Chest. Amsterdam: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.chest.2019.04.008. Acesso em: 20 out. 2025. , 2019
APA
Drager, L. F., & Lorenzi Filho, G. (2019). POINT: Should sleep studies be performed for all patients with poorly controlled hypertension? yes [Editorial]. Chest. Amsterdam: Faculdade de Medicina, Universidade de São Paulo. doi:10.1016/j.chest.2019.04.008
NLM
Drager LF, Lorenzi Filho G. POINT: Should sleep studies be performed for all patients with poorly controlled hypertension? yes [Editorial] [Internet]. Chest. 2019 ; 155( 6): 1095-1097.[citado 2025 out. 20 ] Available from: https://doi.org/10.1016/j.chest.2019.04.008
Vancouver
Drager LF, Lorenzi Filho G. POINT: Should sleep studies be performed for all patients with poorly controlled hypertension? yes [Editorial] [Internet]. Chest. 2019 ; 155( 6): 1095-1097.[citado 2025 out. 20 ] Available from: https://doi.org/10.1016/j.chest.2019.04.008
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CURADO, Thomaz Fleury et al. Neurostimulation treatment of OSA. Chest, v. 154, n. 6, p. 1435-1447, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.chest.2018.08.1070. Acesso em: 20 out. 2025.
APA
Curado, T. F., Oliven, A., Sennes, L. U., Polotsky, V. Y., Eisele, D., & Schwartz, A. R. (2018). Neurostimulation treatment of OSA. Chest, 154( 6), 1435-1447. doi:10.1016/j.chest.2018.08.1070
NLM
Curado TF, Oliven A, Sennes LU, Polotsky VY, Eisele D, Schwartz AR. Neurostimulation treatment of OSA [Internet]. Chest. 2018 ; 154( 6): 1435-1447.[citado 2025 out. 20 ] Available from: https://doi.org/10.1016/j.chest.2018.08.1070
Vancouver
Curado TF, Oliven A, Sennes LU, Polotsky VY, Eisele D, Schwartz AR. Neurostimulation treatment of OSA [Internet]. Chest. 2018 ; 154( 6): 1435-1447.[citado 2025 out. 20 ] Available from: https://doi.org/10.1016/j.chest.2018.08.1070
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANDRADE, Rafaela G. S. et al. Nasal vs oronasal CPAP for OSA treatment a meta-analysis. Chest, v. 153, n. 3, p. 665-674, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.chest.2017.10.044. Acesso em: 20 out. 2025.
APA
Andrade, R. G. S., Viana, F. M., Nascimento, J. de A., Drager, L. F., Moffa, A., Brunoni, A. R., et al. (2018). Nasal vs oronasal CPAP for OSA treatment a meta-analysis. Chest, 153( 3), 665-674. doi:10.1016/j.chest.2017.10.044
NLM
Andrade RGS, Viana FM, Nascimento J de A, Drager LF, Moffa A, Brunoni AR, Genta PR, Lorenzi Filho G. Nasal vs oronasal CPAP for OSA treatment a meta-analysis [Internet]. Chest. 2018 ; 153( 3): 665-674.[citado 2025 out. 20 ] Available from: https://doi.org/10.1016/j.chest.2017.10.044
Vancouver
Andrade RGS, Viana FM, Nascimento J de A, Drager LF, Moffa A, Brunoni AR, Genta PR, Lorenzi Filho G. Nasal vs oronasal CPAP for OSA treatment a meta-analysis [Internet]. Chest. 2018 ; 153( 3): 665-674.[citado 2025 out. 20 ] Available from: https://doi.org/10.1016/j.chest.2017.10.044
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Rogerio. Building the Future of Trial Design in PAH on Solid Ground. Chest. Amsterdam: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.chest.2018.01.041. Acesso em: 20 out. 2025. , 2018
APA
Souza, R. (2018). Building the Future of Trial Design in PAH on Solid Ground. Chest. Amsterdam: Faculdade de Medicina, Universidade de São Paulo. doi:10.1016/j.chest.2018.01.041
NLM
Souza R. Building the Future of Trial Design in PAH on Solid Ground [Internet]. Chest. 2018 ; 153( 5): 1089-1090.[citado 2025 out. 20 ] Available from: https://doi.org/10.1016/j.chest.2018.01.041
Vancouver
Souza R. Building the Future of Trial Design in PAH on Solid Ground [Internet]. Chest. 2018 ; 153( 5): 1089-1090.[citado 2025 out. 20 ] Available from: https://doi.org/10.1016/j.chest.2018.01.041
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
UCHOA, Carlos Henrique G. e DRAGER, Luciano Ferreira. OSA and Prognosis After Acute Cardiogenic Pulmonary Edema The OSA-CARE Study. Chest, v. 152, n. 6, p. 1230-1238, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.chest.2017.08.003. Acesso em: 20 out. 2025.
APA
Uchoa, C. H. G., & Drager, L. F. (2017). OSA and Prognosis After Acute Cardiogenic Pulmonary Edema The OSA-CARE Study. Chest, 152( 6), 1230-1238. doi:10.1016/j.chest.2017.08.003
NLM
Uchoa CHG, Drager LF. OSA and Prognosis After Acute Cardiogenic Pulmonary Edema The OSA-CARE Study [Internet]. Chest. 2017 ; 152( 6): 1230-1238.[citado 2025 out. 20 ] Available from: https://doi.org/10.1016/j.chest.2017.08.003
Vancouver
Uchoa CHG, Drager LF. OSA and Prognosis After Acute Cardiogenic Pulmonary Edema The OSA-CARE Study [Internet]. Chest. 2017 ; 152( 6): 1230-1238.[citado 2025 out. 20 ] Available from: https://doi.org/10.1016/j.chest.2017.08.003
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANDRADE, Rafaela Garcia Santos de et al. Impact of Acute Changes in CPAP Flow Route in Sleep Apnea Treatment. Chest, v. 150, n. 6, p. 1194-1201, 2016Tradução . . Disponível em: https://doi.org/10.1016/j.chest.2016.04.017. Acesso em: 20 out. 2025.
APA
Andrade, R. G. S. de, Lorenzi Filho, G., Genta, P. R., Gregorio, M. G., Sardinha, P. S., Schorr, F., et al. (2016). Impact of Acute Changes in CPAP Flow Route in Sleep Apnea Treatment. Chest, 150( 6), 1194-1201. doi:10.1016/j.chest.2016.04.017
NLM
Andrade RGS de, Lorenzi Filho G, Genta PR, Gregorio MG, Sardinha PS, Schorr F, Piccin VS, Madeiro F, Moriya HT. Impact of Acute Changes in CPAP Flow Route in Sleep Apnea Treatment [Internet]. Chest. 2016 ;150( 6): 1194-1201.[citado 2025 out. 20 ] Available from: https://doi.org/10.1016/j.chest.2016.04.017
Vancouver
Andrade RGS de, Lorenzi Filho G, Genta PR, Gregorio MG, Sardinha PS, Schorr F, Piccin VS, Madeiro F, Moriya HT. Impact of Acute Changes in CPAP Flow Route in Sleep Apnea Treatment [Internet]. Chest. 2016 ;150( 6): 1194-1201.[citado 2025 out. 20 ] Available from: https://doi.org/10.1016/j.chest.2016.04.017
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NERBASS, Flávia Baggio et al. Acute Effects of Nasal CPAP in Patients With Hypertrophic Cardiomyopathy. Chest, 2016Tradução . . Disponível em: https://doi.org/10.1016/j.chest.2016.05.004. Acesso em: 20 out. 2025.
APA
Nerbass, F. B., Salemi, V. M. C., Pedrosa, R. P., Portilho, N. de P., Ferreira Filho, J. C. A., Antunes, M. de O., et al. (2016). Acute Effects of Nasal CPAP in Patients With Hypertrophic Cardiomyopathy. Chest. doi:10.1016/j.chest.2016.05.004
NLM
Nerbass FB, Salemi VMC, Pedrosa RP, Portilho N de P, Ferreira Filho JCA, Antunes M de O, Arteaga-Fernández E, Drager LF, Lorenzi Filho G, Moriya HT. Acute Effects of Nasal CPAP in Patients With Hypertrophic Cardiomyopathy [Internet]. Chest. 2016 ;[citado 2025 out. 20 ] Available from: https://doi.org/10.1016/j.chest.2016.05.004
Vancouver
Nerbass FB, Salemi VMC, Pedrosa RP, Portilho N de P, Ferreira Filho JCA, Antunes M de O, Arteaga-Fernández E, Drager LF, Lorenzi Filho G, Moriya HT. Acute Effects of Nasal CPAP in Patients With Hypertrophic Cardiomyopathy [Internet]. Chest. 2016 ;[citado 2025 out. 20 ] Available from: https://doi.org/10.1016/j.chest.2016.05.004
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEDROSA, Rodrigo P et al. OSA is common and independently associated with hypertension and increased arterial stiffness in consecutive perimenopausal women. Chest, v. 146, n. 1, p. 66-72, 2014Tradução . . Disponível em: https://doi.org/10.1378/chest.14-0097. Acesso em: 20 out. 2025.
APA
Pedrosa, R. P., Barros, I. M., Drager, L. F., Bittencourt, M. S., Medeiros, A. kelley L., Carvalho, L. L., et al. (2014). OSA is common and independently associated with hypertension and increased arterial stiffness in consecutive perimenopausal women. Chest, 146( 1), 66-72. doi:10.1378/chest.14-0097
NLM
Pedrosa RP, Barros IM, Drager LF, Bittencourt MS, Medeiros A kelley L, Carvalho LL, Lustosa TC, Carvalho MMB, Ferreira MNL, Lorenzi-Filho G, Costa LOBF. OSA is common and independently associated with hypertension and increased arterial stiffness in consecutive perimenopausal women [Internet]. Chest. 2014 ; 146( 1): 66-72.[citado 2025 out. 20 ] Available from: https://doi.org/10.1378/chest.14-0097
Vancouver
Pedrosa RP, Barros IM, Drager LF, Bittencourt MS, Medeiros A kelley L, Carvalho LL, Lustosa TC, Carvalho MMB, Ferreira MNL, Lorenzi-Filho G, Costa LOBF. OSA is common and independently associated with hypertension and increased arterial stiffness in consecutive perimenopausal women [Internet]. Chest. 2014 ; 146( 1): 66-72.[citado 2025 out. 20 ] Available from: https://doi.org/10.1378/chest.14-0097
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SIMONNEAU, Gérald et al. Effect of Macitentan on Long-term Outcomes in Patients With Pulmonary Arterial Hypertension (PAH): Subanalysis of SERAPHIN Comparing Incident and Prevalent Patient Populations Not Treated With Background PAH-Specific Therapy. Chest. Chicago: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://journal.publications.chestnet.org/solr/searchresults.aspx?q=rog%C3%A9rio%20souza&allJournals=1&restypeid=3. Acesso em: 20 out. 2025. , 2013
APA
Simonneau, G., Channick, R., Delcroix, M., Galiè, N., Ghofrani, H., Jansa, P., et al. (2013). Effect of Macitentan on Long-term Outcomes in Patients With Pulmonary Arterial Hypertension (PAH): Subanalysis of SERAPHIN Comparing Incident and Prevalent Patient Populations Not Treated With Background PAH-Specific Therapy. Chest. Chicago: Faculdade de Medicina, Universidade de São Paulo. doi:10.1378/chest.1701395
NLM
Simonneau G, Channick R, Delcroix M, Galiè N, Ghofrani H, Jansa P, Le Brun F-O, Mehta S, Perchenet L, Pulido T, Sastry B, Sitbon O, Torbicki A, Rubin L. Effect of Macitentan on Long-term Outcomes in Patients With Pulmonary Arterial Hypertension (PAH): Subanalysis of SERAPHIN Comparing Incident and Prevalent Patient Populations Not Treated With Background PAH-Specific Therapy [Internet]. Chest. 2013 ; 144( 4): 876A.[citado 2025 out. 20 ] Available from: http://journal.publications.chestnet.org/solr/searchresults.aspx?q=rog%C3%A9rio%20souza&allJournals=1&restypeid=3
Vancouver
Simonneau G, Channick R, Delcroix M, Galiè N, Ghofrani H, Jansa P, Le Brun F-O, Mehta S, Perchenet L, Pulido T, Sastry B, Sitbon O, Torbicki A, Rubin L. Effect of Macitentan on Long-term Outcomes in Patients With Pulmonary Arterial Hypertension (PAH): Subanalysis of SERAPHIN Comparing Incident and Prevalent Patient Populations Not Treated With Background PAH-Specific Therapy [Internet]. Chest. 2013 ; 144( 4): 876A.[citado 2025 out. 20 ] Available from: http://journal.publications.chestnet.org/solr/searchresults.aspx?q=rog%C3%A9rio%20souza&allJournals=1&restypeid=3
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CHANNICK, Richard et al. Do Parameters of Cardiac Function Predict Long-term Outcomes in Patients With Pulmonary Arterial Hypertension? Data From SERAPHIN, a Randomized Controlled Study of Macitentan. Chest. Chicago: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://journal.publications.chestnet.org/solr/searchresults.aspx?q=rog%C3%A9rio%20souza&allJournals=1&restypeid=3. Acesso em: 20 out. 2025. , 2013
APA
Channick, R., Delcroix, M., Galiè, N., Ghofrani, H. A., Jansa, P., Le Brun, F. -O., et al. (2013). Do Parameters of Cardiac Function Predict Long-term Outcomes in Patients With Pulmonary Arterial Hypertension? Data From SERAPHIN, a Randomized Controlled Study of Macitentan. Chest. Chicago: Faculdade de Medicina, Universidade de São Paulo. doi:10.1378/chest.1701395
NLM
Channick R, Delcroix M, Galiè N, Ghofrani HA, Jansa P, Le Brun F-O, Mehta S, Perchenet L, Pulido T, Souza R, Sastry B, Sitbon O, Torbicki A, Rubin L, Simonneau G. Do Parameters of Cardiac Function Predict Long-term Outcomes in Patients With Pulmonary Arterial Hypertension? Data From SERAPHIN, a Randomized Controlled Study of Macitentan [Internet]. Chest. 2013 ; 144( 4): 870B.[citado 2025 out. 20 ] Available from: http://journal.publications.chestnet.org/solr/searchresults.aspx?q=rog%C3%A9rio%20souza&allJournals=1&restypeid=3
Vancouver
Channick R, Delcroix M, Galiè N, Ghofrani HA, Jansa P, Le Brun F-O, Mehta S, Perchenet L, Pulido T, Souza R, Sastry B, Sitbon O, Torbicki A, Rubin L, Simonneau G. Do Parameters of Cardiac Function Predict Long-term Outcomes in Patients With Pulmonary Arterial Hypertension? Data From SERAPHIN, a Randomized Controlled Study of Macitentan [Internet]. Chest. 2013 ; 144( 4): 870B.[citado 2025 out. 20 ] Available from: http://journal.publications.chestnet.org/solr/searchresults.aspx?q=rog%C3%A9rio%20souza&allJournals=1&restypeid=3